Resources | NITAG RESOURCE CENTER

2024 ∙ NACI

Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19

2023 ∙ CAVEI

CAVEI recommendation on incorporation of a monoclonal antibody for passive immunization against respiratory syncytial virus in infants in the Program National Immunization

2023 ∙ CAVEI

CAVEI RECOMMENDATION ON VACCINATION INCORPORATION AGAINST RESPIRATORY SYNCYCIAL VIRUS IN OLDER ADULTS AND PREGNANT WOMEN IN THE NATIONAL IMMUNIZATION PROGRAM

2023 ∙ CAVEI

update of the CAVEI recommendation on vaccination against HPV

2023 ∙ CAVEI

CAVEI recommendation on updating the vaccination strategy against COVID-19 by 2024

2023 ∙ CoNaIn

CoNaIn 9th November 2023 meeting minutes

2023 ∙ NACI

Updated guidance on the use of COVID-19 vaccines in individuals who have not previously been vaccinated against COVID-19

2023 ∙ ACIP

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 Influenza Season

2023 ∙ NACI, Anne Pham-Huy, Joseline Zafack, Courtney Primeau, Oliver Baclic, Marina Salvadori, Shelley Deeks

A National Advisory Committee on Immunization (NACI) update on invasive meningococcal disease (IMD) epidemiology and program-relevant considerations for preventing IMD in individuals at high risk of exposure

2023 ∙ ACIP

Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices